Objective: To assess the effect of long-chain polyunsaturated fatty acids (LCPUFA)-and vitamin Esupplemented formula feeding on erythrocyte and plasma a-tocopherol (VE), and plasma retinol (VA) concentrations in neonates and to compare these values with those found in infants feeding on infant formula without LCPUFA or breast milk Setting: University Hospital of Granada, Spain. Subjects: 49 full-term infants. Design and intervention: Subjects who chose not to breast feed were fed either (i) unsupplemented infant formula (F) or (ii) infant formula supplemented with LCPUFA and vitamin E (FL). a-Tocopherol and retinol were measured at 7 days, 1 month and 3 months. Results: Plasma and erythrocyte VE concentrations and plasma VE/total lipids ratio increased signi®cantly in all groups at 1 month of life (P`0.05), but did not change signi®cantly between 1 month and 3 months in any group (P b 0.05). Erythrocyte VE and VA retinol concentrations were higher in infants fed an infant formula than in breast milk-fed infants at 1 month of life (P`0.05). Finally, there were no signi®cant differences in plasma or erythrocyte VE levels, plasma VA or plasma VE/total lipid ratio between any groups at 3 months of life (P b 0.05). Conclusion: Infants fed on LCPUFA-and vitamin E-supplemented infant formula for 3 months have similar vitamin E and A status to infants fed on breast milk or infant formula without LCPUFA supplementation.
Introduction a-Tocopherol is the major physiological fat-soluble antioxidant and contributes considerably to the total radicaltrapping antioxidant potential of the organism (Wayner et al, 1987) . It is taken up by the fat-soluble structure of the cellular membrane and it stabilizes long-chain polyunsaturated fatty acids (LCPUFA) (Niki et al, 1989) . LCPUFA contain up to six double bonds, and so, they are prone to oxidation. Infant membranes are more sensitive to oxidative stress than adult ones since they contain more LCPUFA, and they therefore have higher vitamin E requirements (Vanderpas & Vertongen, 1985; Jain, 1989; Miyake et al, 1991) . Breast-fed infants receive a high dose of vitamin E in the breast milk, particularly in the colostrum, consequently their serum vitamin E concentrations increase progressively, and within 4 to 6 days of breast feeding, restoration to serum levels comparable to those in adults occurs in a signi®cant number of infants (Ostrea et al, 1986) . The concentrations of the nutrients in infant formulas should result in similar serum and erythrocyte levels, and at the same time assure similar growth and development of the formula-fed infants to that seen in breast-fed infants (Bendich & Brock, 1997 ). An infant formula including LCPUFA must provide suf®cient antioxidant protection not only to support storage and manufacturing processes but also to ensure that these antioxidants reach cell membranes in suf®cient numbers after their absorption and provide ef®cient protection for LCPUFA.
Infants are born with signi®cantly lower plasma levels of a-tocopherol and retinol than their mothers, but erythrocyte a-tocopherol levels are similar in neonates and mothers (Vobecky et al, 1982; Ostrea et al, 1986; Kelly et al, 1990; Kaempf et al, 1994; Jain et al, 1996) . Low plasma a-tocopherol concentrations in neonates are due, mainly, to low plasma lipid levels (Ha Èga & Kran, 1982) .
The majority of studies on the in¯uence of the diet of atocopherol levels in infants analyse only plasma a-tocopherol levels (Phelps & Dietz, 1981; Martõ Ânez et al, 1984; Gross & Gabriel, 1985; Ostrea et al, 1986; Hayes et al, 1992; Uauy et al, 1994; Decsi & Koletzko, 1995; Koletzko et al, 1995a) , although some studies show a closer relation between erythrocyte and platelet a-tocopherol with a-tocopherol dietetic changes than for plasma values both in adults and in neonates studies (Mino, 1982; Haddad et al, 1985; Lehmann et al, 1988; Saito et al, 1992; Koletzko et al, 1995b; Rodriguez-Palmero et al, 1997a) .
We studied the evolution of erythrocyte a-tocopherol levels over three months in infants fed formulas and infants fed breast milk. We also assesed the effect on plasma and erythrocyte a-tocopherol concentrations in neonates fed long-chain polyunsaturated fatty acids (LCPUFA)-and atocopherol-supplemented infant formula. However, the enrichement of LCPUFA and vitamin E in the diet may affect, indirectly, other labile micronutrients such as retinol (Nair et al, 1993; Wolmarans et al, 1993) , essential for growth and directly related to visual capacity. For this reason, another aim of this study was to assess the effects of administration of LCPUFA-supplemented infant formula on retinol concentration in the blood.
Methods
Experimental design and subjects Seventy-®ve term infants born at the University Hospital of Granada (Spain) entered the trial. Twenty-six infants were withdrawn in the ®rst week and their measurements were not analysed because they changed from breast milk to formula feed or vice versa. Only 49 neonates enrolled in our study at birth were available to the analyses at one week. Eligible subjects were full-term infants (37±42 weeks gestation), of appropriate weight for gestation age, with 1 min Apgar scores greater than 7. No infant had delivery complications, evidence of intra-uterine malnutrition, congenital malformations or metabolic abnormalities, and their mothers had experienced normal pregnancy. Both cesarean and vaginally delivered infants participated in this study and the lactating mother's choice of type of feeding was respected. None of the mothers was a vegetarian. The study protocol was approved by the Hospital ethics committee. Each mother of a healthy infant was interviewed to determine her choice of feed and interest in participation in the study antenatally and, occasionally, immediately following delivery. Written, informed consent was obtained from the parents for each infant before the ®rst feed.
All mothers were encouraged to breast feed. If they chose formula feeding, infants were assigned to one of the two formula groups using a computer-generated randomization table (IDV Rancode). One group (F) received a commercially available formula based on cow's milk and vegetable fats with a conventional lipid composition including linoleic (Ln) and a-linolenic acids (LnL) (Dorlat 1 , Laboratorios Ordesa, Barcelona, Spain); the other group (FL) received a similar formula enriched, by the manufacturer, with LCPUFA (derived from egg lipids) and vitamin E. Data on fat content, fatty acid composition and retinol and a-tocopherol contents (manufacturer's data) of the two formulas are shown in Table 1 .
In addition, 10 healthy adult volunteers chosen at random from a group of age 25±47 years, from Barcelona, were enrolled for comparative purposes.
Blood sampling and analysis
Venous blood was sampled in the morning on extraction days prior to feeding. Of the 49 infants enrolled at birth only 43 had been fed on the same feeding at 1 month of age and were available for the analysis. Thirty-®ve infants were available at 3 months. Blood samples were collected in brown polypropylene tubes containing ethylene diamine tetraacetate (EDTA) as anticoagulant, 15% in saline solution. Plasma and erythrocytes were separated by centrifugation at 3000 g for 5 min. Plasma was coded and immediately frozen at 7 80 C. Red blood cells were washed three times in saline solution containing 0.15 mol/l NaCl and 1 mmol/l tripotassium ethylenediamine tetraacetate (EDTA K3) at pH 7. The washed cells were resuspended in a saline solution containing 0.15 mol/l NaCl, 1 mmol/l EDTA K3 and 0.5% pyrogallol as antioxidant. Hematocrits were determined and erythrocyte suspensions were coded and stored at 7 80 C. Plasma and erythrocytes were preserved in liquid nitrogen and own from Granada to Barcelona, where they were preserved at 7 80 C until analysis. Blood samples from adult volunteers were collected and separated in Barcelona. Preliminary experiments were performed to ensure that the methods of shipment resulted in the delivery of frozen samples, and that there was no change in vitamin composition in transit.
Vitamin E was determined as a-tocopherol, which provides 95% of the physiological antioxidant activity of vitamin E, in plasma and erythrocytes. Vitamin A was determined as retinol. We used direct extraction without saponi®cation and reversed-phase high-performance liquid chromatography (HPLC) to measure the vitamins, as described previously (Gonza Âlez-Corbella et al, 1994) . In brief, 100 ml of plasma or 150 ml of erythrocyte suspension samples was taken. Methanol with internal standards (atocopherol acetate and retinol acetate) and n-hexane were added. After centrifugation, the organic phase was evaporated, resuspended in methanol and injected. The analytical column used was Spherisorb ODS-2 (250 6 4.6 mm I.D., 5 mm particle size) at 50 C. Isocratic elution was performed a LCPUFA, long-chain polyunsaturated fatty acidsÐ C20:2n-6, C20:3n-6, C20:4n-6, C22:4n-6, C22:5n-6, C20:5n-3, C22:5n-3 and C22:6n-3. b n.d., not detected.
Effects of LCPUFA-enriched formula feeding MJ Gonza Âlez-Corbella et al with methanol at a¯ow rate of 1.0 ml/min. Retinol and atocopherol were measured with a diode-array ultraviolet detector at 325 nm and 292 nm, respectively. The concentrations in erythrocytes obtained from HPLC were corrected by hematocrit values in each sample. Total lipid concentration was measured by a colorimetric method (Diagnos, France) (Zoellner & Kirsch, 1962) . Plasma and erythrocyte fatty acids were directly transesteri®ed without previous lipid extaction, by the method proposed by Rodriguez-Palmero & Lo Âpez (Rodriguez-Palmero et al, 1997b) . The esteri®cation requires methanol±toluene and acetyl choride at 100 C for 1 h. Separation was performed by gas±liquid chromatography.
Peroxide values and malondiadehyde content of both infant formulas were analysed at 0, 30 and 90 days to assess their stability to oxidation. Peroxide value (PV) in infant formulas was determined by the Spanish standard methods (AENOR, 1973) , and malondialdehyde determination was by HPLC (Wong et al, 1994) .
Statistical analysis
Each sample was analysed in duplicate, and the results are reported as means and standard errors (s.e.m.). Results were evaluated with Statgraphics, Release 7.0 (Statistical Graphics Corporation, USA). The statistical methods included one-way analysis of variance (ANOVA) for differences detected between feeding groups, and two-tailed Student's test for unpaired observations to evaluate differences. For differences detected within feeding groups we ®rst used ANOVA and then the two-tailed Student's test for paired observations. We used regression analysis to test correlations between biochemical measurements. The level of statistical signi®cance was set at 5% for all analyses.
Results
Peroxide values of the infant formula without LCPUFA at 0 months, 1 month and 3 months of storage were 0.16, 0.21 and 0.42 meq/kg, respectively. The supplemented LCPUFA and vitamin E formula had values of 0.15, 0.22 and 0.42 meq/kg, respectively. MDA was not detected at any time in any infant formula. Tables 2 and 3 show plasma and erythrocyte a-tocopherol and retinol concentrations in infants fed for 1 week, 1 month or 3 months on formula or maternal milk. Adult plasma a-tocopherol levels (9.59 AE 0.55 mgVE/l, mean AE s.e.m.) were higher than 1 week-old infants levels (Table 2) , but there were no signi®cant differences in erythrocyte a-tocopherol levels between adults (2.96 AE 0.57 mg/l packet cell) and 1-week-old infants. Infants at 1 month and 3 months of life had higher erythrocyte a-tocopherol levels than adults, but there were no differences in plasma a-tocopherol levels. On the other hand, retinol levels were higher in adults (0.41 AE 0.03 mg/l, mean AE s.e.m.) than in infants aged 1 week and at 1 month, but not at 3 months (Table 2) .
In infants, plasma and erythrocyte a-tocopherol and plasma a-tocopherol/total lipid ratio increased signi®cantly at 1 month of age in all three fed groups, but they did not change signi®cantly between 30 and 90 days in any group. We obtained the same results for erythrocyte and plasma atocopherol to LCPUFA ratio (Table 3 ). However, the Identical superscript indicates signi®cant differences between fed groups, due to diet. *Indicates signi®cant differences within fed-groups, differences due to age (P`0.05). n number of infants a LCPUFA included C20:2n-6, C20:3n-6, C20:4n-6, C22:4n-6, C22:5n-6, C20:5n-3, C22:5n-3 and C22:6n-3 *Indicates signi®cant differences within groups (P`0.01).
Effects of LCPUFA-enriched formula feeding MJ Gonza Âlez-Corbella et al statistically signi®cant rise in retinol levels was shown later, between 1 month and 3 months of age. Erythrocyte a-tocopherol concentration and plasma retinol concentration were higher in the groups fed with formula (LCPUFA-F, F) than in the HM group at 1 month. There were no signi®cant differences, due to diet, in plasma or erythrocyte a-tocopherol concentrations, plasma retinol concentration, plasma a-tocopherol/total lipid ratio and plasma or erythrocyte a-tocopherol to LCPUFA ratio between the groups at 3 months of life.
Discussion
Neonates at birth have lower plasma vitamin E levels than adults (Ha Èga & Kran, 1982) . Moreover, plasma vitamin E levels are closely related to plasma total lipid levels (Horwitt et al, 1972) . Low plasma vitamin E concentrations in neonates are due, mainly, to a low plasma lipid level and they increase postnatally with the dietary a-tocopherol (Ha Èga & Kran, 1982) . The plasma tocopherol/total lipid ratio proposed by Horwitt (Horwitt et al, 1972) is the most reliable index routinely available in humans. Martinez found that the ratio was acceptable ( b 0.8) in neonates, although it was still lower than adult values (Martinez et al, 1981) . All the infants in our study always showed higher ratios than 0.8. There were no signi®cant differences in plasma tocopherol levels, in breast milk-fed or formula-fed infants throughout the study. The greatest rise was produced from 1 week to 1 month, when there were signi®cant differences due to age in all groups and in all vitamin E analyses.
There are few studies that analyse plasma or erythrocyte vitamin E in full-term infants fed with LCPUFA-supplemented formula and compare the results with infants fed on human milk. Decsi & Koletzko compared a-tocopherol concentrations of two groups of infants fed infant formula with or without LCPUFA (0.9% LCPUFA, w/w) and 6 mg/l of vitamin E over 4 months; the two fed groups showed similar plasma a-tocopherol levels from 5 days of age until the end of the study (Decsi & Koletzko, 1995) . These authors did not compare plasma a-tocopherol levels of infants fed infant formula with a group fed human milk.
In other studies, full-term infants fed infant formulas without LCPUFAs and a similar amount of vitamin E (6± 6.5 mg/l) for 1 week did not achieve a similar plasma or erythrocyte a-tocopherol increase to that of infants fed on human milk, and the difference was greater in erythrocytes than in plasma (Mino et al, 1982; Paredes et al, 1990) . Infants fed formulas containing higher amounts of vitamin E without LCPUFAs (9.1±11.6 mg/l) showed a progressive increase in their plasma vitamin E similar to those achieved in human milk-fed infants after 1 week (Ostrea et al, 1986) . Restored serum levels were comparable to those in adults. Data on erythrocyte a-tocopherol levels were not given. Kaempf et al in 1994 analysed a-tocopherol levels in blood cells. All infants were fed on formula with 6.5 mg/l of atocopherol, the amount used in the study by Mino et al cited previously. They showed a great increase in their erythrocyte a-tocopherol levels between 1 week and 4 months of age and these levels remained constant until 11 months, when there was a decrease in erythrocyte atocopherol levels to values similar to these at birth. They did not give data on the erythrocyte a-tocopherol rise in full-term infants fed breast milk (Kaempf et al, 1994) .
We extend the information from these previous studies. We found erythrocyte a-tocopherol levels in the neonatal period comparable to those of adults (Mino et al, 1982 (Mino et al, , 1985 Mino, 1992; Kaempf et al, 1994) , but, as found by Kaempf, they rose during the ®rst months of life (Kaempf et al, 1994) . We used infant formulas with a higher amount of vitamin E than in those used in other studies and, although the infants fed on formula had a higher erythrocyte vitamin E concentration at 1 month than infants fed on human milk at 3 months, the differences were not signi®-cant. Infants fed on formulas increased erythrocyte vitamin E levels to the same extent as infants fed on human milk.
Some studies show that erythrocytes and platelets have closer relation to long-term dietetic changes than plasma (Haddad et al, 1985; Lehmann et al, 1988; Saito et al, 1992; Rodriguez-Palmero et al, 1997) . In studies on rats, low doses of ®sh oil (with a large concentration of LCPUFA) enriched with a-tocopherol led to a marked increase a-tocopherol in erythrocytes (Garrido et al, 1989) and in heart (Chautan et al, 1990) . In adults, a metabolic control mechanism speci®cally modulates membrane tocopherol content by homoeostatically ensuring membrane integrity despite the high PUFA content (Berlin et al, 1992) and LCPUFA supplementation in infants may have similar effects. While we did not ®nd signi®cant differences in plasma vitamin E in any infant group at 1 month of life, we detected higher erythrocyte vitamin E levels in infants fed on formula with or without supplementation than in infants fed on human milk.
Breast-fed infants receive a high dose of vitamin E in the breast milk, particularly in the colostrum. Consequently, their serum vitamin E concentrations increase progressively and, within 4±6 days of breast feeding, restoration to serum levels comparable to those in adults occurs in a signi®cant number of the infants (Ostrea et al, 1986) . However, atocopherol absorption is different in infants fed on human milk and those fed on formulas. Natural lactation increases the absorption and bioavailability of fat-soluble vitamins (Gross & Gabriel, 1985) , since breast milk stimulates bile salt production. The high concentration of vitamin E in breast milk must provide infant defence against oxygen toxicity. This is important since term newborns are exposed to an oxygen tension approximately ®ve times greater than that experienced during intra-uterine development (Crawfort, Ghebremeskel & Phylactos, 1995) . Infants are more sensitive to oxidative stress than adults, given the higher amounts of PUFA in their membranes (Jain, 1989; Mino et al, 1989; Miyake et al, 1991) .
Fatty acid unsaturation exponentially increases the rate of oxidation and, although the amount of LCPUFA in the supplemented formula was low, the formula-fed infants need great antioxidant protection. Thus, supplemented formula has higher amount of vitamin E than infant formula without LCPUFA, but a-tocopherol levels in plasma and erythrocytes of infants fed one or another infant formula were similar at the end of the study. The oxidation parameters, such as peroxide value or malondialdehyde concentration, of both formulas indicate that they remained stable during the study.
Since preterm neonates are more susceptible to vitamin E de®ciency, it is more dif®cult to establish the appropiate content of a-tocopherol in preterm infant formulas. It has been reported that preterm neonates fed infant formula without LCPUFA, but containing 20 mg/l of vitamin E and 0.8 mg/l of iron reached equal serum a-tocopherol Effects of LCPUFA-enriched formula feeding MJ Gonza Âlez-Corbella et al concentrations to preterm neonates fed human milk for 42 days. However, they had a lower serum peroxyl radical trapping capacity (TRAP assay) (Van Zoeren-Grobben et al, 1994) , although a-tocopherol contributes considerably to the total radical trapping antioxidant potential of the organism (Wayner et al, 1987) . The role of vitamin A is particularly critical during periods of rapid growth and tissue development, both in infancy and in early childhood (Underwood, 1994) . Retinol levels are lower in 1 week-old infants than in adults. Neonates have lower mean plasma vitamin A levels than their mothers at delivery, which may be a re¯ection of age rather than a true de®ciency, since age-related changes in these vitamin levels have been reported (Olson, 1984) . Plasma levels of vitamin A below 0.2 mg/l indicate depletion in hepatic stores (Olson, 1984) ; here, however, the mean vitamin A values found were above this limit at 7 days, 1 month and 3 months of life, so no de®ciency was recorded. These results agree with those of other authors who found similar plasma vitamin A levels for term infants in industrialized countries (Ala-Houhala et al, 1988; Bougle Â et al, 1990) . The retinol concentration in milk declines 50% over the ®rst 4±8 weeks post partum, which could explain the differences found after 1 month between infants fed on formula and those fed on human milk.
The main ®nding of this study is that infants fed for 3 months with an infant formula supplemented with LCPUFA and vitamin E showed no signi®cant differences in their plasma or erythrocyte a-tocopherol, plasma retinol, or plasma a-tocopherol/total lipid ratio compared to infants fed with human milk or formula without LCPUFA. The infant formula studied here contained suf®cient tocopherol to guarantee physiological tocopherol levels in erythrocytes and plasma. Moreover, we found a great increase in the erythrocyte a-tocopherol levels between 1 week and 3 months of age both in infant formula-fed and breast milkfed infants.
